🔎 Trials Near Me

Akèy › Fibroz sistik › Massachusetts

Etid klinik pou Fibroz sistik nan Massachusetts

17 etid pou Fibroz sistik ap chèche patisipan nan sit nan Massachusetts.

Vil nan Massachusetts

Tèks ofisyèl etid la (Anglè)

Phase 2 Study to Assess the Safety and Efficacy of ANG003

  • Massachusetts General Hospital, Boston
  • Boston Children's Hospita, Boston
Ap rekriteFaz 2
Laj 12 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07450547

Streamlined Treatment of Pulmonary Exacerbations in Pediatrics

  • Boston Children's Hospital & Harvard University, Boston
Ap rekrite
Laj 3 a 18 · Tout sèks · Mizajou Aug 3, 2026 · NCT06654752

Study to Evaluate Biological & Clinical Effects of Significantly Corrected CFTR Function in Infants & Young Children

  • Boston Children's Hospital, Boston
Ap rekriteEtid obsèvasyon
Jiska laj 10 · Tout sèks · Mizajou Jul 8, 2026 · NCT04509050

Standardizing Treatments for Pulmonary Exacerbations - Aminoglycoside Study

  • Boston Children's Hospital, Brigham & Women's Hospital, Boston
  • University of Massachusetts Memorial Health Care, Worcester
Ap rekriteFaz 4
Laj 6 ak plis · Tout sèks · Mizajou Jul 8, 2026 · NCT05548283

4D-710 in Adult Patients With Cystic Fibrosis

  • Massachusetts General Hospital, Boston
  • Boston Children's Hospital, Boston
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jul 6, 2026 · NCT05248230

TIDES 2.0: Prevalence and Longitudinal Course of Depression, Anxiety, and Behavior Problems in Children With Cystic Fibrosis Under 12 Years of Age

  • Massachusetts General Hospital, Boston
Ap rekriteEtid obsèvasyon
18 Months – 11 Years · Tout sèks · Mizajou Jul 6, 2026 · NCT07048574

Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPL84 in Patients With Cystic Fibrosis

  • Boston Children'S Hospital, Boston
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou May 14, 2026 · NCT06429176

Safety, Tolerability and Efficacy Study of ARCT-032 in People With Cystic Fibrosis

  • Boston Children's Hospital, Boston
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou May 8, 2026 · NCT06747858

CF Wellness Program

  • Boston Children's Hospital, Boston
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Feb 13, 2026 · NCT07071324

Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)

  • Massachusetts, Boston
Ap rekriteEtid obsèvasyon
Laj 12 ak plis · Tout sèks · Mizajou Feb 10, 2026 · NCT06837181

OnTrackCF: Engagement, Feasibility, and Acceptability Study

  • Boston Children's Hospital, Boston
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Dec 5, 2025 · NCT07031323

Health Outcomes of Parents With Cystic Fibrosis-Aim 2

  • Massachusetts General Hospital, Boston
  • Boston Children's Hospital/Brigham and Women's Hospital, Boston
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Nov 10, 2025 · NCT06296394

Restarting Triple Therapy With Robust Monitoring for Adverse Events (RETRIAL)

  • Massachusetts General Hospital, Boston
  • Boston Children's Hospital, Boston
Ap rekriteEtid obsèvasyon
Laj 6 ak plis · Tout sèks · Mizajou Nov 3, 2025 · NCT06683092

Skeletal Health and Bone Marrow Composition in Adolescents With Cystic Fibrosis

  • Boston Children's Hospital, Boston
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 13 a 20 · Tout sèks · Mizajou Oct 30, 2025 · NCT06216704

A Research Study to Advance the CF Therapeutics Pipeline for People Without Modulators

  • Massachusetts General Hospital, Boston
  • Boston Children's Hospital, Boston
  • University of Massachusetts Memorial Health Care, Worcester
Ap rekriteEtid obsèvasyon
Laj 12 ak plis · Tout sèks · Mizajou Oct 1, 2025 · NCT06504589

The Effects of a Low Glycemic Load Diet on Dysglycemia and Body Composition in Adults With Cystic Fibrosis-Related Diabetes

  • Boston Children's Hospital, Boston
Ap rekrite
Laj 18 a 70 · Tout sèks · Mizajou Aug 22, 2025 · NCT05723445

A Phase 1/2 Trial of SP-101 for the Treatment of Cystic Fibrosis (CF)

  • Boston Children's Hospital, Brigham & Women's Hospital, Boston
Ap rekriteFaz 1/2
Laj 18 a 65 · Tout sèks · Mizajou Nov 25, 2024 · NCT06526923

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.